1715 related articles for article (PubMed ID: 29477146)
1. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
3. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
4. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Salles GC; Leite NC; Salles GF
Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
[TBL] [Abstract][Full Text] [Related]
7. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort.
Slieker RC; van der Heijden AAWH; Nijpels G; Elders PJM; 't Hart LM; Beulens JWJ
Cardiovasc Diabetol; 2019 Dec; 18(1):170. PubMed ID: 31830993
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of short-term ambulatory blood pressure variability for microvascular and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Salles GC; Leite NC; Salles GF
J Hypertens; 2021 May; 39(5):935-946. PubMed ID: 33239549
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
10. Visit-to-Visit HbA
Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; van Greevenbroek MMJ; de Jong M; Vos RC; Bots ML; Reulen JPH; Houben AJHM; Webers CAB; Berendschot TTJM; Dagnelie PC; Eussen SJPM; Schram MT; Koster A; Peters SAE; Stehouwer CDA
Cardiovasc Diabetol; 2021 May; 20(1):102. PubMed ID: 33962619
[TBL] [Abstract][Full Text] [Related]
12. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
Mäkimattila S; Schlenzka A; Mäntysaari M; Bergholm R; Summanen P; Saar P; Erkkilä H; Yki-Järvinen H
Diabetes Care; 2000 Nov; 23(11):1686-93. PubMed ID: 11092293
[TBL] [Abstract][Full Text] [Related]
13. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
14. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
16. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
18. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
[TBL] [Abstract][Full Text] [Related]
20. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
